BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of GBP 775.66 million. The enterprise value is 679.55 million.
Market Cap | 775.66M |
Enterprise Value | 679.55M |
Important Dates
The next estimated earnings date is Friday, July 18, 2025.
Earnings Date | Jul 18, 2025 |
Ex-Dividend Date | May 8, 2025 |
Share Statistics
Current Share Class | 98.50M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 73.43M |
Valuation Ratios
The trailing PE ratio is 32.48.
PE Ratio | 32.48 |
Forward PE | n/a |
PS Ratio | 7.09 |
PB Ratio | 5.65 |
P/TBV Ratio | 6.22 |
P/FCF Ratio | 28.63 |
P/OCF Ratio | 28.18 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.05, with an EV/FCF ratio of 25.08.
EV / Earnings | 28.45 |
EV / Sales | 6.22 |
EV / EBITDA | 20.05 |
EV / EBIT | 21.31 |
EV / FCF | 25.08 |
Financial Position
The company has a current ratio of 10.84
Current Ratio | 10.84 |
Quick Ratio | 8.31 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 206.82 |
Financial Efficiency
Return on equity (ROE) is 15.69% and return on invested capital (ROIC) is 13.13%.
Return on Equity (ROE) | 15.69% |
Return on Assets (ROA) | 11.48% |
Return on Invested Capital (ROIC) | 13.13% |
Return on Capital Employed (ROCE) | 22.02% |
Revenue Per Employee | 488,526 |
Profits Per Employee | 106,621 |
Employee Count | 225 |
Asset Turnover | 0.63 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.65% in the last 52 weeks. The beta is 0.65, so BioGaia AB's price volatility has been lower than the market average.
Beta (5Y) | 0.65 |
52-Week Price Change | -24.65% |
50-Day Moving Average | 104.26 |
200-Day Moving Average | 111.84 |
Relative Strength Index (RSI) | 36.22 |
Average Volume (20 Days) | 32,948 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of GBP 109.43 million and earned 23.88 million in profits. Earnings per share was 0.24.
Revenue | 109.43M |
Gross Profit | 79.67M |
Operating Income | 31.96M |
Pretax Income | 30.54M |
Net Income | 23.88M |
EBITDA | 33.28M |
EBIT | 31.96M |
Earnings Per Share (EPS) | 0.24 |
Balance Sheet
The company has 96.33 million in cash and n/a in debt, giving a net cash position of 96.33 million.
Cash & Cash Equivalents | 96.33M |
Total Debt | n/a |
Net Cash | 96.33M |
Net Cash Per Share | n/a |
Equity (Book Value) | 137.18M |
Book Value Per Share | 1.36 |
Working Capital | 114.04M |
Cash Flow
In the last 12 months, operating cash flow was 27.53 million and capital expenditures -436,582, giving a free cash flow of 27.09 million.
Operating Cash Flow | 27.53M |
Capital Expenditures | -436,582 |
Free Cash Flow | 27.09M |
FCF Per Share | n/a |
Margins
Gross margin is 72.81%, with operating and profit margins of 29.20% and 21.83%.
Gross Margin | 72.81% |
Operating Margin | 29.20% |
Pretax Margin | 27.91% |
Profit Margin | 21.83% |
EBITDA Margin | 30.41% |
EBIT Margin | 29.20% |
FCF Margin | 24.76% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.50%.
Dividend Per Share | 0.54 |
Dividend Yield | 0.50% |
Dividend Growth (YoY) | 5.77% |
Years of Dividend Growth | 1 |
Payout Ratio | 61.94% |
Buyback Yield | -0.13% |
Shareholder Yield | 0.37% |
Earnings Yield | 3.08% |
FCF Yield | 3.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
Last Split Date | May 18, 2022 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |